Further investigation of morphine 3-glucuronide's role in the dose-limiting excitatory side-effects of morphine administered chronically to cancer patients (1998–1999)

Grant type:
Queensland Cancer Fund
  • Director, CIPDD
    UQ Centre for Clinical Research
    Faculty of Medicine
    School of Pharmacy
    Faculty of Health and Behavioural Sciences
    Affiliate Professor
    Institute for Molecular Bioscience
Funded by:
Queensland Cancer Fund